| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |